CPT® Code 90471

Last Updated: February 2026 | Verified for 2026 AMA, CPT & CMS Guidance

Quick Reference:

• What 90471 means: Immunization administration for one vaccine given by injection route (percutaneous, intradermal, subcutaneous, or intramuscular). It represents the administration service—the vaccine product is billed separately.
• One “first injection” per encounter: Report 90471 once for the first injected vaccine in the encounter, then use the appropriate add-on administration code (typically +90472) for additional injected vaccines given the same day. Repeating 90471 for multiple injections in the same encounter is a common denial trigger.
• Do not mix immunization administration families on the same date (Medicare): CMS NCCI policy instructs that immunization administration for influenza/pneumococcal/hepatitis B preventive vaccines uses G0008/G0009/G0010, while other immunizations use either 90460–90461 or 90471–90474 (depending on counseling/age/route). A provider should not report a combination of codes from these families for immunizations on a single date of service.
• E/M same day requires true separateness: An office/outpatient E/M service may be reportable with vaccine administration when it is significant and separately identifiable from the immunization work; append modifier 25 to the E/M when appropriate. CMS NCCI guidance also states that 99211 is not separately reportable with vaccine administration codes.
• Documentation is audit-critical: CDC guidance requires recording (at minimum) administration date, manufacturer, lot number, administrator name/title, facility address, and the VIS edition date plus the date VIS was provided (when VIS is required). For multiple vaccines, document the injection site mapping (which vaccine went in which arm/leg).
• COVID-19 administration is a different family: CMS transmittal materials describe a 2026 descriptor revision for CPT 90480 and establish add-on CPT 90481. Do not assume COVID-19 administration is coded with 90471; follow the COVID-specific administration instructions in the applicable CMS implementation guidance. CPT 90471 is the foundational vaccine administration code for injection-route immunizations when (a) counseling-based pediatric administration (90460–90461) does not apply, (b) oral/intranasal administration codes (90473–90474) are not appropriate, (c) Medicare preventive administration G-codes are required, and (d) COVID-19 administration follows its own code family and implementation rules.

The highest reimbursement and audit risk with 90471 is not the descriptor itself—it is misclassification into the wrong administration family, incorrect counting when multiple vaccines are given, and documentation that fails to prove what was administered, how, and under what legal/CDC recordkeeping standards.

1. CPT 90471 Definition and Procedure Scope

Exact descriptor (administration only). CPT 90471 is defined as: “Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid).” This code reports the work of administration for one injected vaccine during the encounter—not the vaccine product itself. Vaccine product codes are reported separately on the claim.

What counts as “one vaccine” in 90471. For 90471, the unit is the administration of one vaccine product by injection route during the encounter. It is not a “component count” model. The component-based logic belongs to the counseling-based pediatric administration family (90460–90461), which is structured differently and should be used only when its counseling and age requirements are met and documented.

Route matters: 90471 is limited to injection routes (percutaneous, intradermal, subcutaneous, intramuscular). If the vaccine is administered orally or intranasally, use the oral/intranasal administration family (90473 for the first, +90474 for additional) rather than 90471.

Compliance boundary: Many denials occur because “immunization given” is documented without the route, the product identity, or the legal VIS fields. When the record cannot prove the injection and its documentation requirements, payers may deny the administration line even if the product line is paid, or recoup both after audit.

2. Administration Code Selection Logic (90471 vs related codes)

Correct coding starts with a disciplined selection process. In immunization billing, the most common error is selecting an administration code family based on habit (e.g., “we always use 90471”) rather than applying payer rules and CPT/CMS administration families. CMS NCCI policy is explicit that different immunization categories have different administration coding pathways in Medicare claims processing.

2.1 Practical selection framework (2026)

Key operational point: A “vaccine-only visit” often includes brief screening (contraindications, allergies, vitals) and documentation. That work is typically inherent to immunization administration. If a separate problem-oriented evaluation occurs, it may support a separate E/M with modifier 25, but that should be documentation-driven—not reflexive.

3. CMS/Medicare Rules and NCCI Bundling: Prohibited Combinations, E/M, Modifiers

In 2026, the most defensible approach is to treat CMS NCCI policy as the baseline for Medicare claims processing logic. NCCI does not replace CPT, but it operationalizes how Medicare adjudicates combinations of codes, which is the practical source of denials and post-payment audit findings.

3.1 “Do not mix administration families” (Medicare)

CMS NCCI policy explains that administration of influenza, pneumococcal, or hepatitis B vaccine is reported with G0008, G0009, or G0010, respectively. Administration of other immunizations “not excluded by law” is reported with either CPT 90460–90461 or CPT 90471–90474 depending on patient age and physician counseling. Critically, NCCI indicates that a provider should not report a combination of codes from these immunization administration code families for immunizations on a single date of service in Medicare claims processing.

Common Medicare denial pattern: A clinic gives (1) influenza vaccine and (2) a non-influenza vaccine on the same day, then reports G0008 and 90471. In Medicare contexts where the G-code pathway applies, mixed-family billing can trigger denials or require correction depending on the specific scenario and CMS processing rules. Use NCCI as the first-line “what will Medicare accept” reference.

3.2 E/M services on the same day: modifier 25 and the 99211 constraint

CMS NCCI policy permits reporting immunization administration codes with a significant, separately identifiable E/M service when the E/M is truly distinct from the immunization work. In such cases, the E/M code is reported with modifier 25. NCCI also includes a high-yield constraint for vaccine visits: CPT 99211 is not separately reportable with vaccine administration HCPCS/CPT codes. This rule is commonly implicated when practices bill minimal-level nurse visits alongside immunization administration.

NCCI’s broader modifier-25 principles emphasize that modifier 25 is appropriate only when the E/M work is above and beyond the usual work inherent in the procedure performed on that day. In immunization settings, the “usual work” includes screening, consent, and routine counseling directly related to vaccination; therefore, documentation must demonstrate separate problem assessment/management if an E/M is reported.

3.3 Modifier 59 and X{E,S,P,U}: rarely a default in vaccination, but important when edits occur

Most immunization claim problems are solved by correct family selection and correct counting of administrations—not by modifiers. However, when NCCI edits or payer-specific edits require demonstration of a distinct service, CMS MLN guidance describes modifier 59 and the more specific X modifiers (XE/XS/XP/XU). These modifiers should be used only when the record supports a distinct procedural service (for example, distinct encounter/session or other distinctness consistent with the edit rationale).

High-risk behavior: Appending modifier 59 to “force payment” for services that are not actually distinct is a classic audit trigger. In immunization contexts, start by confirming correct administration coding (90471 once + add-on codes for additional injections, correct family selection) and ensure documentation supports the services billed before using modifiers for edit resolution.

3.4 COVID-19 administration: recognize the separate CMS implementation stream

CMS transmittal guidance for January 2026 includes changes tied to COVID-19 administration code descriptors and the establishment of a COVID add-on code. The practical takeaway for 90471 workflows is simple: do not assume COVID-19 administration belongs under 90471. If COVID-19 vaccination is part of the encounter, the claim must follow the current COVID administration code family and CMS implementation instructions applicable to the date of service and setting.

4. Documentation Standards and Audit-Proofing

Immunization claims are unusually documentation-sensitive because (a) vaccination has legal recordkeeping requirements, (b) vaccine products must be traceable for recall and safety, and (c) payers commonly audit vaccines due to volume and preventive benefit designs. CDC’s “After Giving Vaccine” guidance summarizes the core data elements that should be recorded in the patient’s permanent medical record.

4.1 Minimum documentation elements (CDC)

CDC guidance indicates that the permanent record should include, at minimum, the vaccine administration date, vaccine manufacturer, vaccine lot number, and the name and title of the person administering the vaccine, along with the facility address where the record resides. CDC also specifies that documentation should include the VIS edition date and the date the VIS was provided to the patient/parent/legal representative when VIS requirements apply.

4.2 VIS documentation: a frequent audit failure point

CDC VIS instructions emphasize recordkeeping of both the VIS edition date and the date it was provided. For many organizations, this is best captured through structured EHR immunization modules rather than free-text notes, because the VIS fields are easy to omit in narrative documentation. VIS omissions can cause problems even when the vaccination itself was clinically appropriate and accurately billed.

4.3 Multiple vaccines in the same visit: site mapping supports correct coding

When more than one vaccine is administered in a single visit, documentation should clearly map each vaccine to an anatomic site (e.g., “Influenza IM left deltoid; Tdap IM right deltoid”). CDC best practices on vaccine administration support detailed site documentation, which becomes the practical defense for add-on administration billing and helps resolve “duplicate line” denials.

Audit-proofing checklist for CPT 90471 encounters:

(1) vaccine product identity; (2) route (IM/SC/ID/percutaneous); (3) site; (4) date/time (if recorded in your system); (5) manufacturer; (6) lot number; (7) administrator identity and facility address; (8) VIS edition date and date provided (when required); (9) if a separate E/M is billed, documentation supporting a distinct complaint/assessment/plan beyond immunization work.

5. Reimbursement Reality: Medicare Methodology and Why “One Rate” Is Misleading

Practices often ask for “the reimbursement for CPT 90471,” but a single nationwide number is not a rigorous answer. CMS physician payment is determined by RVUs (work, practice expense, malpractice), multiplied by a conversion factor, then adjusted by geographic practice cost indices (GPCIs). As a result, allowed amounts vary by locality and, for some services, may vary by facility vs non-facility context. The most authoritative public explanation of this methodology is CMS’s Physician Fee Schedule final rule fact sheet for CY 2026.

Practical billing implication: If you need a defensible allowed-amount estimate for budgeting, use the appropriate CMS fee schedule lookup tools and apply your locality and site-of-service assumptions. For compliance writing, the most reliable approach is to explain the CMS methodology (which is stable) and avoid quoting a single dollar figure unless it is retrieved directly from an official CMS table for the relevant locality and setting.

6. Real-World Billing Examples

Scenario 1: Adult receives one injected vaccine in a nurse vaccination clinic

Setting: Physician office vaccine clinic (no separately documented problem-oriented evaluation).

Service: One injected vaccine administered (IM).

Administration coding logic: Report 90471 for the administration (product code billed separately). Ensure the record includes lot/manufacturer and VIS fields as applicable.

E/M: Do not bill an E/M solely for routine vaccination workflow; if an E/M is billed, documentation must show significant, separately identifiable evaluation/management beyond the vaccination work, and Medicare logic must be respected (including the 99211 constraint).

Scenario 2: Adult receives two injected vaccines during the same encounter (non-COVID)

Setting: Primary care office visit where vaccines are administered.

Service: Two injected vaccines given (e.g., IM deltoids).

Administration coding logic: Report 90471 once for the first injected vaccine, and use the appropriate add-on administration code (commonly +90472) for the additional injected vaccine. Document a clear site map linking each vaccine to its site.

Denial prevention tip: If the claim repeats 90471 for the second injection without a clear basis, payers may deny as duplicate/incorrect unit reporting. NCCI principles favor correct add-on reporting and clear documentation.

Scenario 3: Pediatric patient ≤18 with counseling by physician/QHP

Setting: Pediatric office visit where the physician/QHP provides face-to-face vaccine counseling.

Service: Injection vaccine administered; counseling documented.

Administration coding logic: Use the counseling-based pediatric administration family when counseling is documented and requirements are met; do not default to 90471. In Medicare claims processing, do not mix counseling-based codes with 90471–90474 on the same date.

Audit-proofing tip: The record should make counseling explicit (who counseled, face-to-face, and content/intent) because retrospective audits commonly recoup counseling-based administration when counseling is not documentable.

Scenario 4: Vaccine encounter plus significant, separately identifiable problem-oriented evaluation

Setting: Primary care visit where the patient presents with a complaint and also receives vaccination.

Service: Vaccination plus evaluation/management for a separate complaint.

Administration coding logic: Bill vaccine administration per route/family (90471 pathway if injection and counseling-based pediatric pathway does not apply).

E/M coding logic: If the E/M work is significant and separately identifiable from vaccination workflow, append modifier 25 to the E/M. Avoid 99211 with vaccine administration in Medicare contexts per NCCI.

Scenario 5: COVID-19 vaccination performed during a broader immunization visit

Setting: Clinic provides COVID-19 vaccine along with other services.

Service: COVID-19 vaccine administration (and possibly other vaccines).

Coding logic: Follow CMS implementation guidance on COVID-19 administration descriptors and add-on structures effective in 2026; do not assume COVID administration is billed under 90471. If other vaccines are administered, apply NCCI “family” logic carefully and avoid mixing families in Medicare claims processing.

7. Short FAQ

When should 90471 be used?

Use 90471 for the first injected vaccine administration in an encounter when counseling-based pediatric administration does not apply and when a different Medicare preventive administration pathway or other specific administration family does not govern the encounter. Always confirm route and payer family rules first.

Can I bill 90471 twice if two injections are given?

Typically, no. Report 90471 once for the first injected vaccine, and report the appropriate add-on administration code for additional injected vaccines given in the same encounter. Repeating 90471 is a common denial pattern unless a payer has an explicit alternative instruction (rare) and the documentation supports it. Medicare NCCI logic is designed around correct family selection and add-on usage.

Do I always bill an E/M with vaccines?

No. An E/M is billable only when it is significant and separately identifiable beyond routine vaccination work. When appropriate, modifier 25 is appended to the E/M. Medicare NCCI also indicates that 99211 is not separately reportable with vaccine administration codes.

Which documentation fields are most likely to be checked in audits?

CDC guidance emphasizes administration date, manufacturer, lot number, administrator identity/title, facility address, and VIS edition date plus VIS-given date (where VIS applies). For multiple vaccines, document each injection site and map it to the vaccine administered at that site.

Should modifier 59 be used to solve vaccine denials?

Usually not. Most vaccine denials are corrected by selecting the correct administration family and documenting clearly. Modifier 59 (or X modifiers) is reserved for specific “distinct procedural service” situations supported by documentation, consistent with CMS MLN guidance.